Login

Ipca Laboratories Ltd.

₹1378.2

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Ipca Laboratories Ltd.

₹1378.2

₹1378.2

-23.0 (-1.64%) - 3 May 2025 04:27 PM

About Company

IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are sold in many countries across the globe. The company has numerous manufacturing units in India manufacturing API’s and formulations for the world market. The company is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India.

Market Cap. ₹34,966 Cr.
52 Week - High/Low ₹1,756/1,052
P/E Ratio 44.79
P/B Ratio 5.51
Enterprise Value ₹35,643 Cr.
ROE % 8.68
RSI Value 46.70
EMA 50 1416.74
EMA 200 1419.75
Net Profit 530 Cr.
Net Profit 3year growth -53.5 Cr.
Net Profit 3 year (back) 1,141 Cr.
Debt to Equity 0.18 %
EPS Growth TTM 34.96 %
Current Ratio 2.31 %
100 Day SMA 1,478 Rs.
200 Day SMA 1,467 Rs.
21 Day SMA 1,403 Rs.
50 Day SMA 1,400 Rs.
Book Value 250 Rs.
EV/EBITDA Ratio 25
QoQ EPS Growth 10 %
QoQ Operating Profit Growth 2 %
QoQ Sales Growth -8 %
Sales Latest Quarter 1,663 Cr.
YoY Sales Growth 10 %
Market Cap. ₹34,966 Cr.
52 Week - High/Low ₹1,756/1,052
P/E Ratio 47.92
P/B Ratio 5.52
Enterprise Value ₹35,683 Cr.
ROE % 8.7
RSI Value 46.70
EMA 50 1416.74
EMA 200 1419.75
Net Profit 547 Cr.
Net Profit 3year growth 9.7 Cr.
Net Profit 3 year (back) 1,140 Cr.
Debt to Equity 0.22 %
EPS Growth TTM 29.26 %
Current Ratio 2.35 %
100 Day SMA 1,478 Rs.
200 Day SMA 1,467 Rs.
21 Day SMA 1,403 Rs.
50 Day SMA 1,400 Rs.
Book Value 250 Rs.
EV/EBITDA Ratio 23
QoQ EPS Growth 8 %
QoQ Operating Profit Growth 5 %
QoQ Sales Growth -5 %
Sales Latest Quarter 2,245 Cr.
YoY Sales Growth 9 %
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.